USP17L1

gene
On this page

Summary

USP17L1 (ubiquitin specific peptidase 17 like family member 1, HGNC:37182) is a protein-coding gene on chromosome 8p23.1, encoding Ubiquitin carboxyl-terminal hydrolase 17-like protein 1 (Q7RTZ2). Deubiquitinating enzyme that removes conjugated ubiquitin from specific proteins to regulate different cellular processes that may include cell proliferation, progression through the cell cycle, apoptosis, cell migration, and the cellular response to viral infection.

Predicted to enable cysteine-type deubiquitinase activity. Predicted to be involved in regulation of apoptotic process and regulation of protein stability. Predicted to be located in endoplasmic reticulum. Predicted to be active in cytosol and nucleus.

Source: NCBI Gene 401447 — RefSeq curated summary.

At a glance

  • Clinical variants (ClinVar): 1 total
  • MANE Select transcript: NM_001256873

Identifiers

Gene identifiers

FieldValue
HGNC IDHGNC:37182
Approved symbolUSP17L1
Nameubiquitin specific peptidase 17 like family member 1
Location8p23.1
Locus typegene with protein product
StatusApproved
Ensembl geneENSG00000230549
Ensembl biotypeprotein_coding
Entrez401447

Gene structure

Transcript identifiers

Ensembl transcripts: 1 — 1 protein_coding

ENST00000529559

RefSeq mRNA: 1 — MANE Select: NM_001256873 NM_001256873

CCDS: CCDS78298

Canonical transcript exons

ENST00000529559 — 1 exons

ExonStartEnd
ENSE0000216433573323877333979

Expression profiles

Bgee: expression breadth broad, 13 present calls, max score 47.73.

Top tissues by expression

113 total, by Bgee expression score (0-100, higher = more expressed):

TissueAnatomy IDExpression scoreQuality
ventricular zoneUBERON:000305347.73gold quality
cortical plateUBERON:000534346.11gold quality
ganglionic eminenceUBERON:000402344.07silver quality
sural nerveUBERON:001548837.52gold quality
colonic epitheliumUBERON:000039737.20gold quality
bone marrow cellCL:000209236.16gold quality
superior frontal gyrusUBERON:000266135.45gold quality
C1 segment of cervical spinal cordUBERON:000646935.10silver quality
skeletal muscle tissueUBERON:000113434.84gold quality
right frontal lobeUBERON:000281034.69silver quality
urinary bladderUBERON:000125533.84gold quality
hypothalamusUBERON:000189833.37silver quality
cerebral cortexUBERON:000095632.59silver quality
substantia nigraUBERON:000203832.47silver quality
brainUBERON:000095532.42silver quality
hindlimb stylopod muscleUBERON:000425232.15gold quality
muscle tissueUBERON:000238532.13gold quality
bone marrowUBERON:000237131.74gold quality
tonsilUBERON:000237230.20gold quality
stromal cell of endometriumCL:000225529.87gold quality
skin of abdomenUBERON:000141629.36gold quality
placentaUBERON:000198729.18gold quality
zone of skinUBERON:000001428.88gold quality
liverUBERON:000210728.71gold quality
islet of LangerhansUBERON:000000628.31gold quality
skin of legUBERON:000151128.26gold quality
duodenumUBERON:000211428.14gold quality
adrenal tissueUBERON:001830327.84gold quality
ovaryUBERON:000099227.79silver quality
muscle of legUBERON:000138327.58gold quality

Single-cell (SCXA)

Detected in 1 experiment(s), a significant marker in 0.

ExperimentMarker?Max mean expression
E-ANND-3no0.33

Regulation

Is transcription factor: no

Cross-species orthologs

0 orthologs

Paralogs (71): USP2 (ENSG00000036672), USP28 (ENSG00000048028), USP36 (ENSG00000055483), USP13 (ENSG00000058056), USP33 (ENSG00000077254), USP40 (ENSG00000085982), USP48 (ENSG00000090686), USP14 (ENSG00000101557), USP11 (ENSG00000102226), USP10 (ENSG00000103194), USP31 (ENSG00000103404), USP42 (ENSG00000106346), USP5 (ENSG00000111667), USP4 (ENSG00000114316), USP9Y (ENSG00000114374), USP34 (ENSG00000115464), USP35 (ENSG00000118369), USP45 (ENSG00000123552), USP22 (ENSG00000124422), USP9X (ENSG00000124486), USP6 (ENSG00000129204), USP29 (ENSG00000131864), USP26 (ENSG00000134588), USP30 (ENSG00000135093), USP15 (ENSG00000135655), USP37 (ENSG00000135913), USP44 (ENSG00000136014), USP20 (ENSG00000136878), USP8 (ENSG00000138592), USP3 (ENSG00000140455), USP21 (ENSG00000143258), USP43 (ENSG00000154914), USP25 (ENSG00000155313), USP16 (ENSG00000156256), USP24 (ENSG00000162402), USP1 (ENSG00000162607), USP49 (ENSG00000164663), USP38 (ENSG00000170185), USP50 (ENSG00000170236), USP47 (ENSG00000170242)

Protein

Protein identifiers

Ubiquitin carboxyl-terminal hydrolase 17-like protein 1Q7RTZ2 (reviewed: Q7RTZ2)

Alternative names: Deubiquitinating enzyme 17-like protein 1, Ubiquitin thioesterase 17-like protein 1, Ubiquitin-specific-processing protease 17-like protein 1

All UniProt accessions (1): Q7RTZ2

UniProt curated annotations — full annotation on UniProt →

Function. Deubiquitinating enzyme that removes conjugated ubiquitin from specific proteins to regulate different cellular processes that may include cell proliferation, progression through the cell cycle, apoptosis, cell migration, and the cellular response to viral infection.

Subcellular location. Nucleus. Endoplasmic reticulum.

Similarity. Belongs to the peptidase C19 family. USP17 subfamily.

RefSeq proteins (1): NP_001243802* (*=MANE)

Domains & families (InterPro)

IDNameType
IPR001394Peptidase_C19_UCHDomain
IPR018200USP_CSConserved_site
IPR028889USPDomain
IPR038765Papain-like_cys_pep_sfHomologous_superfamily
IPR050164Peptidase_C19Family

Pfam: PF00443

UniProt features (7 total): compositionally biased region 2, active site 2, chain 1, domain 1, region of interest 1

Structure

Experimental structures (PDB)

0 structures.

Predicted structure (AlphaFold)

ModelpLDDTFraction very-high
AF-Q7RTZ2-F167.650.44

Functional residue map

Curated UniProt residues grouped by drug-discovery relevance — catalytic, ligand-binding, modification, and mutation-validated positions. Source: UniProtKB sequence features.

Catalytic / active sites (2): 89 (nucleophile); 334 (proton acceptor)

Function

Pathways and Gene Ontology

Reactome pathways

1 pathways

IDPathway
R-HSA-5689880Ub-specific processing proteases

MSigDB gene sets: 14 (showing top): GOBP_PROTEIN_MODIFICATION_BY_SMALL_PROTEIN_REMOVAL, GOMF_CYSTEINE_TYPE_PEPTIDASE_ACTIVITY, GOBP_POST_TRANSLATIONAL_PROTEIN_MODIFICATION, GOBP_REGULATION_OF_PROTEIN_STABILITY, GOBP_PROTEOLYSIS, GOMF_PEPTIDASE_ACTIVITY, GOMF_UBIQUITIN_LIKE_PROTEIN_PEPTIDASE_ACTIVITY, REACTOME_POST_TRANSLATIONAL_PROTEIN_MODIFICATION, REACTOME_DEUBIQUITINATION, REACTOME_UB_SPECIFIC_PROCESSING_PROTEASES, GOBP_REGULATION_OF_PROGRAMMED_CELL_DEATH, GOBP_PROTEIN_MODIFICATION_PROCESS, GOMF_DEUBIQUITINASE_ACTIVITY, chr8p23

GO Biological Process (5): proteolysis (GO:0006508), apoptotic process (GO:0006915), protein deubiquitination (GO:0016579), regulation of protein stability (GO:0031647), regulation of apoptotic process (GO:0042981)

GO Molecular Function (4): cysteine-type deubiquitinase activity (GO:0004843), peptidase activity (GO:0008233), cysteine-type peptidase activity (GO:0008234), hydrolase activity (GO:0016787)

GO Cellular Component (3): nucleus (GO:0005634), endoplasmic reticulum (GO:0005783), cytosol (GO:0005829)

Reactome top-level categories

Rollup of top-1 pathways:

CategoryPathways
Deubiquitination1

GO top-level categories

Rollup of top GO terms by namespace:

CategoryTerms
intracellular membrane-bounded organelle2
cytoplasm2
protein metabolic process1
programmed cell death1
apoptotic signaling pathway1
execution phase of apoptosis1
cysteine-type deubiquitinase activity1
protein modification by small protein removal1
regulation of biological quality1
apoptotic process1
regulation of programmed cell death1
cysteine-type peptidase activity1
deubiquitinase activity1
hydrolase activity1
catalytic activity, acting on a protein1
peptidase activity1
catalytic activity1
endomembrane system1
cellular anatomical structure1

Protein interactions and networks

STRING

168 interactions, top by confidence (×1000):

Protein AProtein BPartner UniProtScore
USP17L1FAM90A10A6NDY2661
USP17L1PRAMEF25A6NGN4519
USP17L1DEFB107AQ8IZN7479
USP17L1XKR5Q6UX68447
USP17L1ZSCAN4Q8NAM6430
USP17L1DEFB108BQ8NET1400
USP17L1ZNF735P0CB33393
USP17L1TMEM92Q6UXU6380
USP17L1PRR23BQ6ZRT6371
USP17L1PRR23AA6NEV1370
USP17L1PRR23D1E9PI22370
USP17L1DEFB105AQ8NG35339
USP17L1Q3LFD5Q3LFD5336
USP17L1DEFB106AQ8N104332
USP17L1USP54Q70EL1325

IntAct

2 interactions, top by confidence:

ABTypeScore
Mpsi-mi:“MI:0914”(association)0.350

BioGRID (6): USP17L1 (Affinity Capture-MS), USP17L1 (Affinity Capture-MS), ATP5I (Cross-Linking-MS (XL-MS)), USP17L1 (Cross-Linking-MS (XL-MS)), USP17L1 (Affinity Capture-MS), USP17L1 (Affinity Capture-MS)

ESM2 similar proteins: A2A5N8, A6NCW0, A6NCW7, A8MUK1, B1AQJ2, B2RQC2, C9J2P7, C9JJH3, C9JLJ4, C9JPN9, C9JVI0, D3ZWK4, D6R901, D6R9N7, D6RA61, D6RBM5, D6RBQ6, D6RCP7, D6RJB6, E9Q9U0, G5E8G2, G5E8I7, O94966, P0C7H9, P0C7I0, P35125, P51784, Q0E2F9, Q0WX57, Q2TAC6, Q3UJD6, Q4KLL9, Q5R7G8, Q5TKR9, Q61068, Q66HE5, Q6J1Y9, Q6PFD6, Q6QN14, Q6R6M4

Diamond homologs: A1L1K8, A6NCW0, A6NCW7, A8MUK1, C9J2P7, C9JJH3, C9JLJ4, C9JPN9, C9JVI0, D6R901, D6R9N7, D6RA61, D6RBQ6, D6RCP7, D6RJB6, G1SW77, P0C7H9, P0C7I0, Q0WX57, Q5JVS0, Q5XJA5, Q6AXS5, Q6NRY1, Q6PB22, Q6R6M4, Q7RTZ2, Q8NC51, Q9CY58, Q9I9R0, Q9JKS5, A1CIL1, A1CW53, A2Q9N1, A4FUN7, A5D9H7, A5PJS6, A5WWB0, A6QR55, B0Y4P5, B2GUZ1

SIGNOR signaling

0 interactions.

Disease & clinical

Clinical variants and AI predictions

ClinVar

1 variants total. Per-class counts are floors (≥ shown; pagination cap):

ClassificationCount (floor)
Pathogenic0
Likely pathogenic0
Uncertain significance0
Likely benign1
Benign0

Top pathogenic / likely-pathogenic (0)

SpliceAI

81 predictions. Top by Δscore:

VariantEffectΔscore
8:7333678:A:Tdonor_gain0.5600
8:7333413:G:GTdonor_gain0.5500
8:7333423:G:GAdonor_gain0.5400
8:7333677:G:GTdonor_gain0.5300
8:7333485:GCC:Gdonor_gain0.4700
8:7333660:TGGA:Tdonor_gain0.4600
8:7333604:A:Tdonor_gain0.4500
8:7333751:CGAAG:Cdonor_loss0.4400
8:7333752:GAAG:Gdonor_loss0.4400
8:7333753:AAG:Adonor_loss0.4400
8:7333754:AG:Adonor_loss0.4400
8:7333755:GGTAC:Gdonor_loss0.4400
8:7333756:G:Cdonor_loss0.4400
8:7333757:T:Adonor_loss0.4400
8:7332501:G:GCacceptor_gain0.3900
8:7333503:A:AGacceptor_gain0.3900
8:7333504:T:Gacceptor_gain0.3900
8:7333750:TCGAA:Tdonor_loss0.3900
8:7333507:A:AGacceptor_gain0.3800
8:7333508:G:GGacceptor_gain0.3800
8:7333750:TCGA:Tdonor_gain0.3800
8:7333508:GAAGA:Gacceptor_gain0.3700
8:7333368:TG:Tdonor_gain0.3600
8:7333369:GG:Gdonor_gain0.3600
8:7333508:GAA:Gacceptor_gain0.3500
8:7333130:A:Tdonor_gain0.3400
8:7333758:A:Cdonor_loss0.3400
8:7332594:C:CGdonor_gain0.3300
8:7332594:C:Gdonor_gain0.3200
8:7333422:T:TAdonor_gain0.3200

AlphaMissense

3499 scored. Top likely-pathogenic:

VariantProtein changeam_pathogenicity
8:7332876:T:CF164L0.880
8:7332878:T:AF164L0.880
8:7332878:T:GF164L0.880
8:7332843:T:CF153L0.857
8:7332845:C:AF153L0.857
8:7332845:C:GF153L0.857
8:7333233:T:CF283L0.850
8:7333235:C:AF283L0.850
8:7333235:C:GF283L0.850
8:7333497:T:CF371L0.834
8:7333499:T:AF371L0.834
8:7333499:T:GF371L0.834
8:7332885:T:CF167L0.832
8:7332887:C:AF167L0.832
8:7332887:C:GF167L0.832
8:7332975:T:CF197L0.824
8:7332977:T:AF197L0.824
8:7332977:T:GF197L0.824
8:7333422:T:AW346R0.741
8:7333422:T:CW346R0.741
8:7333035:T:CF217L0.679
8:7333037:T:AF217L0.679
8:7333037:T:GF217L0.679
8:7332902:G:AM172I0.658
8:7332902:G:CM172I0.658
8:7332902:G:TM172I0.658
8:7333424:G:CW346C0.631
8:7333424:G:TW346C0.631
8:7333406:A:CK340N0.618
8:7333406:A:TK340N0.618

dbSNP variants (sampled 300 via entrez): RS1000492919 (8:7331782 A>T), RS1002166917 (8:7330892 A>G), RS1002302661 (8:7331064 C>G,T), RS1004085959 (8:7331474 C>G), RS1004117089 (8:7331346 C>A,G,T), RS1005438278 (8:7332751 G>A), RS1005739483 (8:7330564 T>G), RS1007975189 (8:7331736 G>A), RS1008422439 (8:7331521 T>C), RS1009010791 (8:7334060 AACACAC>A,AAC,AACAC,AACACACAC,AACACACACAC), RS1009684550 (8:7330614 C>A,T), RS1010064603 (8:7330857 G>A,C,T), RS1012495089 (8:7332674 G>A), RS1013552631 (8:7331243 G>C), RS1014583421 (8:7331117 T>A,C)

Disease associations

OMIM: gene `` | disease phenotypes:

GenCC curated gene-disease

Mondo (0):

Orphanet (0):

HPO phenotypes

0 total (0 of 0 shown, HPO-id order):

GWAS associations

0 associations (top):

Drugs & pharmacology

Drug and pharmacology data

Is drug target: no

PharmGKB: 1 entry (VIP=true, CPIC=false)

CTD chemical–gene interactions

3 total (human), top 3 by PubMed support.

ChemicalActions (top 5)PubMed papers
triphenyltindecreases expression1
tributyltinisothiocyanatedecreases expression1
Benzo(a)pyreneincreases expression1

Clinical trials (associated diseases)

0 trials via MONDO — disease-level, not drug-specific.

No linked Atlas pages yet — the cross-entity mesh grows as the corpus expands.